The Correlation between the Use of the Proton Pump Inhibitor and the Clinical Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

BACKGROUND: To determine if the use of the Proton Pump Inhibitors (PPI) impacts the clinical efficacy of Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC), a meta-analysis was conducted. METHOD: Eleven studies from PubMed, EMBASE, Cochrane Library, Web of Science, and other d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Da-Hai, Wong, Wan-Ching, Zhou, Jia-Xin, Luo, Ji, Cai, Song-Wang, Zhou, Hong, Tang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288308/
https://www.ncbi.nlm.nih.gov/pubmed/35855807
http://dx.doi.org/10.1155/2022/1001796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288308/
https://www.ncbi.nlm.nih.gov/pubmed/35855807
http://dx.doi.org/10.1155/2022/1001796

Ejemplares similares